22 related articles for article (PubMed ID: 3707011)
1. [Experimental characterization of propafenone. Hemodynamic effects].
Botti G; Aurier E; Finardi A
G Ital Cardiol; 1984 May; 14(5):373-6. PubMed ID: 6468819
[TBL] [Abstract][Full Text] [Related]
2. [Effects of propafenone on coronary and systemic hemodynamics].
Terrosu P; Ibba GV; Franceschino V; Contini GM; Delpini A
G Ital Cardiol; 1986 Apr; 16(4):321-7. PubMed ID: 3743935
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the hemodynamic effects and anti-arrhythmic activity of propafenone: from new frontiers to clinical verification].
Lotto A; Finzi A
G Ital Cardiol; 1986 Apr; 16(4):333-5. PubMed ID: 3743936
[No Abstract] [Full Text] [Related]
4. [Hemodynamic action of propafenon in patients with atherosclerotic coronary disease].
Lamounier EN; Martinez Filho EE; Herrmann JL; Guimarães RD; Portugal OP; Barcellini A
Arq Bras Cardiol; 1979 Jul; 33(1):73-6. PubMed ID: 526178
[No Abstract] [Full Text] [Related]
5. Assessment of the antiarrhythmic profile of the new class I agent diprafenone.
Gülker H; Thale J; Olbing B; Heuer H; Frenking B; Bender F
Arzneimittelforschung; 1985; 35(9):1387-93. PubMed ID: 4084340
[TBL] [Abstract][Full Text] [Related]
6. [Propafenone--a new generation anti-arrhythmia agent].
Fischer M
Med Klin; 1980 Jan; 75(1):39-41. PubMed ID: 6988688
[No Abstract] [Full Text] [Related]
7. Propafenone--a new antiarrhythmic drug.
Seipel L; Breithardt G
Eur Heart J; 1980 Aug; 1(4):309-13. PubMed ID: 7023945
[No Abstract] [Full Text] [Related]
8. Physiologic and technical variables affecting hemodynamic measurements.
Schermer L
Crit Care Nurse; 1988; 8(2):33-40, 42. PubMed ID: 3077613
[No Abstract] [Full Text] [Related]
9. [Effects on the systemic and coronary circulation of a new IC-group anti-arrhythmia agent: propafenone. Hemodynamic study of 10 patients in the basal state and under auricular electric stimulation, before and after the intravenous injection of propafenone].
Fernandez F; Boyibanga J; Vrancea F; Maarek-Charbit M; Genet P; Gay J
Ann Cardiol Angeiol (Paris); 1986 Feb; 35(2):119-22. PubMed ID: 3707011
[No Abstract] [Full Text] [Related]
10. [New antiarrythmic drugs: mexiletine, tocainide, lorcainide, encainide, flecainide, propafenone, cipralan, sotalol].
Touboul P; Kirkorian G; Atallah G; Moleur P
Ann Cardiol Angeiol (Paris); 1982 Dec; 31(7):531-7. PubMed ID: 6820620
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
